Cover Story: COMPOUNDING UNDER SIEGE

A majority of patients say that taking cannabis helps them with chronic pain management and other conditions.

Some patients with PAH need to travel long distances, which may impact their access to quality care providers.

A higher dose of the carbonic anhydrase inhibitor does not seem to provide any additional improvements.

The atrial fibrillation drug, asundexian, may provide protection from thrombotic events without a corresponding increase in bleeding risk.

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

The specialty drug pipeline is projected to grow by 8% each year through 2025.